Vivos Inc. (OTCMKTS:RDGL) Short Interest Down 67.8% in February

Vivos Inc. (OTCMKTS:RDGL) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 5,800 shares, a decline of 67.8% from the January 31st total of 18,000 shares. Based on an average daily volume of 2,339,200 shares, the days-to-cover ratio is currently 0.0 days.

Vivos Stock Down 2.4 %

Shares of OTCMKTS:RDGL traded down $0.00 during trading on Friday, reaching $0.11. 1,219,055 shares of the company traded hands, compared to its average volume of 1,358,471. The company’s 50 day moving average is $0.13 and its two-hundred day moving average is $0.13. The firm has a market capitalization of $49.00 million, a PE ratio of -10.80 and a beta of 0.89. Vivos has a 52 week low of $0.05 and a 52 week high of $0.26.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.